Palisade Bio (PALI) Competitors $2.44 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends PALI vs. BCLI, PSTV, NLSP, WENA, SNSE, TLPH, AWH, NKGN, EGRX, and TSBXShould you be buying Palisade Bio stock or one of its competitors? The main competitors of Palisade Bio include Brainstorm Cell Therapeutics (BCLI), Plus Therapeutics (PSTV), NLS Pharmaceutics (NLSP), ANEW Medical (WENA), Sensei Biotherapeutics (SNSE), Talphera (TLPH), Aspira Women's Health (AWH), NKGen Biotech (NKGN), Eagle Pharmaceuticals (EGRX), and Turnstone Biologics (TSBX). These companies are all part of the "medical" sector. Palisade Bio vs. Brainstorm Cell Therapeutics Plus Therapeutics NLS Pharmaceutics ANEW Medical Sensei Biotherapeutics Talphera Aspira Women's Health NKGen Biotech Eagle Pharmaceuticals Turnstone Biologics Brainstorm Cell Therapeutics (NASDAQ:BCLI) and Palisade Bio (NASDAQ:PALI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, community ranking, profitability, valuation and risk. Do analysts rate BCLI or PALI? Brainstorm Cell Therapeutics currently has a consensus price target of $30.00, indicating a potential upside of 2,319.35%. Palisade Bio has a consensus price target of $23.00, indicating a potential upside of 842.62%. Given Brainstorm Cell Therapeutics' higher possible upside, equities analysts plainly believe Brainstorm Cell Therapeutics is more favorable than Palisade Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Brainstorm Cell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Palisade Bio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, BCLI or PALI? Palisade Bio has higher revenue and earnings than Brainstorm Cell Therapeutics. Brainstorm Cell Therapeutics is trading at a lower price-to-earnings ratio than Palisade Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrainstorm Cell TherapeuticsN/AN/A-$17.19M-$4.80-0.26Palisade Bio$250K12.98-$12.30M-$13.98-0.17 Do insiders & institutionals believe in BCLI or PALI? 14.3% of Brainstorm Cell Therapeutics shares are owned by institutional investors. Comparatively, 11.8% of Palisade Bio shares are owned by institutional investors. 6.7% of Brainstorm Cell Therapeutics shares are owned by insiders. Comparatively, 3.3% of Palisade Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is BCLI or PALI more profitable? Brainstorm Cell Therapeutics' return on equity of 0.00% beat Palisade Bio's return on equity.Company Net Margins Return on Equity Return on Assets Brainstorm Cell TherapeuticsN/A N/A -528.56% Palisade Bio N/A -148.51%-115.16% Which has more risk & volatility, BCLI or PALI? Brainstorm Cell Therapeutics has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500. Comparatively, Palisade Bio has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Does the MarketBeat Community believe in BCLI or PALI? Brainstorm Cell Therapeutics received 281 more outperform votes than Palisade Bio when rated by MarketBeat users. Likewise, 61.26% of users gave Brainstorm Cell Therapeutics an outperform vote while only 50.00% of users gave Palisade Bio an outperform vote. CompanyUnderperformOutperformBrainstorm Cell TherapeuticsOutperform Votes29161.26% Underperform Votes18438.74% Palisade BioOutperform Votes1050.00% Underperform Votes1050.00% Does the media favor BCLI or PALI? In the previous week, Palisade Bio had 1 more articles in the media than Brainstorm Cell Therapeutics. MarketBeat recorded 3 mentions for Palisade Bio and 2 mentions for Brainstorm Cell Therapeutics. Brainstorm Cell Therapeutics' average media sentiment score of 1.00 beat Palisade Bio's score of 0.15 indicating that Brainstorm Cell Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Brainstorm Cell Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Palisade Bio 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryBrainstorm Cell Therapeutics beats Palisade Bio on 8 of the 15 factors compared between the two stocks. Ad InvestorPlaceWhat This Post-Election Shift Means for Your InvestmentsThe election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.Click here now to watch the full briefing and prepare for what's next. Get Palisade Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PALI vs. The Competition Export to ExcelMetricPalisade BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.25M$2.98B$5.15B$8.84BDividend YieldN/A1.91%5.00%4.07%P/E Ratio-0.1743.94126.4617.62Price / Sales12.98284.461,231.1486.42Price / CashN/A169.3840.2336.27Price / Book0.494.416.946.36Net Income-$12.30M-$41.63M$119.54M$225.88M7 Day Performance-3.17%-0.03%0.98%1.84%1 Month Performance-34.05%-5.83%-4.33%1.67%1 Year Performance-71.92%25.21%31.20%26.69% Palisade Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PALIPalisade Bio2.5936 of 5 stars$2.44flat$23.00+842.6%-72.4%$3.25M$250,000.00-0.1710Analyst ForecastGap UpBCLIBrainstorm Cell Therapeutics4.4633 of 5 stars$1.24-1.6%$30.00+2,319.4%-62.4%$7.07MN/A-0.2640Analyst UpgradePositive NewsPSTVPlus Therapeutics3.4048 of 5 stars$1.20+0.8%$14.00+1,066.7%-34.4%$7.08M$4.91M-0.4720Gap UpNLSPNLS Pharmaceutics1.2366 of 5 stars$3.37+2.4%N/A+722.0%$12.85MN/A0.006WENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpSNSESensei Biotherapeutics4.8087 of 5 stars$0.48-2.0%$4.33+795.3%-26.6%$12.17MN/A-0.4140TLPHTalphera2.1466 of 5 stars$0.70-1.4%$4.50+543.6%N/A$12.03M$281,000.00-1.0119Gap UpAWHAspira Women's Health1.6689 of 5 stars$0.75+2.7%$4.40+488.4%-75.7%$12.01M$9.15M-0.62110Analyst ForecastNKGNNKGen BiotechN/A$0.34+6.3%N/A-87.9%$11.94M$80,000.00-0.06N/AGap UpHigh Trading VolumeEGRXEagle Pharmaceuticals1.1133 of 5 stars$0.90+38.5%N/A-89.9%$11.69M$316.61M0.00134Analyst ForecastGap UpTSBXTurnstone Biologics3.2182 of 5 stars$0.47+2.2%$2.13+352.6%-80.8%$10.86M$19.31M-0.1482 Related Companies and Tools Related Companies BCLI Alternatives PSTV Alternatives NLSP Alternatives WENA Alternatives SNSE Alternatives TLPH Alternatives AWH Alternatives NKGN Alternatives EGRX Alternatives TSBX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PALI) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | SponsoredThe AI Crash Begins November 30thMost AI stocks are doomed. I’m not an AI hater. AI will absolutely continue to be the most disruptive tech...Brownstone Research | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palisade Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palisade Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PALI Stock Alerts